文章基本信息

标题：Gerenciamento clínico de eventos tromboembólicos provenientes de complicaes da COVID-19: reviso integrativa
本地全文：下载
作者：Laura Dayane Gois Bispo ; Natan Martins Machado ; Caio Lopes Pinheiro de Paula 等
期刊名称：Research, Society and Development
电子版ISSN：2525-3409
出版年度：2021
卷号：10
期号：13
页码：1-10
DOI：10.33448/rsd-v10i13.21052
语种：English
出版社：Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
摘要：Objective: to identify how the clinical management of patients infected with COVID-19 who present pulmonary thromboembolism and/or venous thromboembolism occurs. Method: This is an integrative review, carried out by searching for articles in the VHL, LILACS, MEDLINE, CINAHL AND SCOPUS databases, with a temporal delimitation from November 2019 to March 2021. Results: 24 articles were included. Diagnosis occurs through D-dimer and fibrinogen. For drug therapy, low molecular weight heparin (LMWH) is administered, 30 mg/12h in 12h for prophylactic anticoagulation, staggered doses of LMWH with enoxaparin, 0.5 mg/kg twice a day for anticoagulation therapy and rivoxaban 10mg/day for post-discharge anticoagulation. Conclusion: Clinical management of TEP and VTE occurs through increased D-dimer or fibrinogen, with TEP confirmed by pulmonary angiography. For anticoagulation, LMWH is mostly used.
关键词：Venous thromboembolism;Pulmonary embolism;COVID-19;Clinical management.